CHR. OLESEN SYNTHESIS A/S: Financial statements 2014
CVR: 33964870
Source: annual report 2014, Danish Business Authority
01/10/2013 – 30/09/2014
CHR. OLESEN SYNTHESIS A/S (CVR 33964870) has filed annual accounts for 2014. In 2014, the company reported a gross profit of EUR -165,799 and a net result of EUR -2,004,972 compared with EUR -1,455,185 the year before. Equity in the 2014 report amounted to EUR -4,625,081.
- Gross Profit
- EUR -165,799
- Profit/Loss
- EUR -2,004,972
- Equity
- EUR -4,625,081
- Total Assets
- EUR 4,889,367
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | -166K EUR | -2M EUR | -4.6M EUR | - |
| 2013 | - | -85 EUR | -1.5M EUR | -2.6M EUR | - |
| 2012 | - | -934K | -1.6M | -1.2M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
CHR. OLESEN SYNTHESIS A/S has published its annual report for 2013. Gross profit came to DKK -85, and the net result was DKK -1,455,185.
About CHR. OLESEN SYNTHESIS A/S
CHR. OLESEN SYNTHESIS A/S is a Danish company of the type Aktieselskab based in Hvidovre, founded in 2011. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The management consists of Thomas Michael Moestrup. The board consists of Jean-Francois Hilaire (chair), Joseph Nivaro and Thomas Michael Moestrup. The company is owned by Samfara/Bering Bidco Limited. The company has 97 employees (2026). In 2025, the company reported a gross profit of EUR 6,958,825 and a net result of EUR -2,299,046 compared with EUR 7,391,800 the year before. Equity in the 2025 report amounted to EUR -9,489,900.
